These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10676424)

  • 1. Distributions of individual susceptibility among humans for toxic effects. How much protection does the traditional tenfold factor provide for what fraction of which kinds of chemicals and effects?
    Hattis D; Banati P; Goble R
    Ann N Y Acad Sci; 1999; 895():286-316. PubMed ID: 10676424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human interindividual variability in parameters related to health risks.
    Hattis D; Banati P; Goble R; Burmaster DE
    Risk Anal; 1999 Aug; 19(4):711-26. PubMed ID: 10765432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A straw man proposal for a quantitative definition of the RfD.
    Hattis D; Baird S; Goble R
    Drug Chem Toxicol; 2002 Nov; 25(4):403-36. PubMed ID: 12378950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective.
    Gundert-Remy U; Sonich-Mullin C;
    Sci Total Environ; 2002 Apr; 288(1-2):3-11. PubMed ID: 12013545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
    Willhite CC; Ball GL; McLellan CJ
    Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human variability in susceptibility to toxic chemicals--a preliminary analysis of pharmacokinetic data from normal volunteers.
    Hattis D; Erdreich L; Ballew M
    Risk Anal; 1987 Dec; 7(4):415-26. PubMed ID: 3444929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zero exposure--a goal for environmental and occupational health?
    Aitio A
    Toxicol Lett; 2002 Aug; 134(1-3):3-8. PubMed ID: 12191855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A procedure for developing risk-based reference doses.
    Gaylor DW; Kodell RL
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in pharmacokinetics between children and adults--II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling.
    Hattis D; Ginsberg G; Sonawane B; Smolenski S; Russ A; Kozlak M; Goble R
    Risk Anal; 2003 Feb; 23(1):117-42. PubMed ID: 12635728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priority assessment of toxic substances in life cycle assessment. Part II: assessing parameter uncertainty and human variability in the calculation of toxicity potentials.
    Huijbregts MA; Thissen U; Jager T; van de Meent D; Ragas AM
    Chemosphere; 2000 Aug; 41(4):575-88. PubMed ID: 10819226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to mixtures of chemical substances: is there a need for regulations?
    Van Zorge JA
    Food Chem Toxicol; 1996; 34(11-12):1033-6. PubMed ID: 9119312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review.
    Dorne JL; Walton K; Renwick AG
    Food Chem Toxicol; 2005 Feb; 43(2):203-16. PubMed ID: 15621332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal threshold of toxicological concern values: enabling route-to-route extrapolation.
    Partosch F; Mielke H; Stahlmann R; Kleuser B; Barlow S; Gundert-Remy U
    Arch Toxicol; 2015 Jun; 89(6):941-8. PubMed ID: 24915937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants.
    Valcke M; Krishnan K
    J Appl Toxicol; 2014 Mar; 34(3):227-40. PubMed ID: 24038072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.